Powerful drug may have been used to kill nursing home COVID patients, says former Pfizer VP

[g]

13 Jan 2022

Former Pfizer Vice President Dr. Michael Yeadon has suggested that a powerful drug may have been used intentionally to hasten the deaths of COVID-19 patients in U.K. nursing homes during the peak of the COVID-19 pandemic.

According to Yeadon, who had also served as the chief scientist of allergy and respiratory research at Pfizer and is now the chief scientific advisor for the Truth for Health Foundation, information has “come to light” indicating that the drug midazolam (a potent sedative which can cause fatal respiratory depression) has “played an important role in the spring 2020 excess deaths.”

“It is alleged that medical procedures were distorted substantially and that, essentially, this drug was used to kill people, very large numbers of people, in the U.K.,” during the early days of the COVID response, Yeadon said during an online conference last year.

The shocking claim, which the U.K.’s Association for Palliative Medicine has strongly denied, is supported by figures which indicate that out-of-hospital prescriptions of midazolam more than doubled in April 2020 compared to prior months, according to the Daily Mail.

While for the past five years an average of 15,000 out-of-hospital midazolam prescriptions were reportedly written monthly in England, in April 2020 that number skyrocketed to 38,582, the Daily Mail reported.

Midazolam is similar to, but “twice as powerful” as diazepam (more commonly known as Valium). It “reduces anxiety, relaxes muscles and, if enough is given, provides ‘total sedation’ for dying patients in extreme pain or distress,” the report continued.

Though a widely used sedative in hospital settings, the depression of breathing caused by the drug can be fatal, particularly in people with suppressed immune systems.

According to an article published by CovidVaccineHub in June 2021, “Midazolam has a United States Food and Drug Administration [FDA] black box warning, which notes that the medication has been associated with respiratory depression and arrest because it can slow or stop breathing.”

“Black box warnings are issued to consumers when medications or products may have serious or life-threatening side effects that could lead to severe illness, hospitalizations, and death,” the resource noted.

Retired neurologist Professor Patrick Pullicino, M.D., who is also a Catholic priest, has argued that since “‘Midazolam depresses respiration,” it also “hastens death,” changing “end-of-life care into euthanasia.”